Data as of Q4 2025 (Dec 31, 2025)

Picard Medical, Inc.

(PMI)

Financial Statements · SEC EDGAR XBRL

Revenue
$4.9M
+12.5%
Net Income
-$27.0M
-28.2%
EPS
$-0.75
+74.9%
Gross Margin
-4.1%
Op. Income
-$13.3M
+3.3%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
$4.9M
$4.4M
$4.9M
$4.4M
$5.1M
$4.5M
-$204K
-$112K
$10.0M
$10.2M
$3.0M
$3.4M
$13.1M
$13.6M
-$13.3M
-$13.7M
-$13.7M
-$7.4M
-$27.0M
-$21.1M
$35K
-$15K
-$27.0M
-$21.1M
$-0.75
$-2.99
$-0.75
$-2.99
36.2M
7.9M